Cargando…

Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description

Growth retardation (stunting, wasting and poor organ development) among children in low-income countries has major short and long-term health consequences yet very little is known about the nutritional and environmental influences on the key hormonal axes regulating child growth in these settings, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Sophie E., Doel, Andrew M., Ong, Ken K., Dunger, David B., Affara, Nabeel A., Prentice, Andrew M., Bernstein, Robin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921526/
https://www.ncbi.nlm.nih.gov/pubmed/33693312
http://dx.doi.org/10.12688/gatesopenres.13101.1
_version_ 1783658488892751872
author Moore, Sophie E.
Doel, Andrew M.
Ong, Ken K.
Dunger, David B.
Affara, Nabeel A.
Prentice, Andrew M.
Bernstein, Robin M.
author_facet Moore, Sophie E.
Doel, Andrew M.
Ong, Ken K.
Dunger, David B.
Affara, Nabeel A.
Prentice, Andrew M.
Bernstein, Robin M.
author_sort Moore, Sophie E.
collection PubMed
description Growth retardation (stunting, wasting and poor organ development) among children in low-income countries has major short and long-term health consequences yet very little is known about the nutritional and environmental influences on the key hormonal axes regulating child growth in these settings, nor the tempo and timing of faltering episodes. Here we describe the study protocol and provide a cohort description of the Hormonal and Epigenetic Regulators of Growth (HERO-G) study. This prospective cohort study from rural Gambia, West Africa, followed mothers and children longitudinally from pre-conception, through pregnancy, delivery, and to two years of child age A total of 251 eligible mother-infant pairs were recruited into the HERO-G study, with 206 (82%) followed up until two years of age. Women were seen at scheduled antenatal appointments at 20, 28 and 36 weeks of gestation, and at delivery, where possible. Between one week and 12 months of age, infants were visited every second day for collection of detailed anthropometry and morbidity data. Infants identified as about to enter a growth faltering episode at these visits entered a more detailed 20-day protocol, with the collection of dried blood spots, anthropometry and body composition. All infants were seen for scheduled clinic visits at 3, 6, 9, 12, 18 and 24 months of age for clinical examination and venous blood draw. Data from the HERO-G study is being used to explore three major mechanistic pathways influencing growth: 1) genome-wide investigations for signatures of epigenetic effects on any loci that might affect growth; 2) frequent anthropometric measurement coupled with non-invasive monitoring for rapid identification and interrogation of real-time faltering patterns and aetiology; 3) focused measurement of hormones and cytokines that act together in an integrated manner, both in utero and after birth, to coordinate patterns of growth with immune activation, inflammation, and nutritional status.
format Online
Article
Text
id pubmed-7921526
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-79215262021-03-09 Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description Moore, Sophie E. Doel, Andrew M. Ong, Ken K. Dunger, David B. Affara, Nabeel A. Prentice, Andrew M. Bernstein, Robin M. Gates Open Res Study Protocol Growth retardation (stunting, wasting and poor organ development) among children in low-income countries has major short and long-term health consequences yet very little is known about the nutritional and environmental influences on the key hormonal axes regulating child growth in these settings, nor the tempo and timing of faltering episodes. Here we describe the study protocol and provide a cohort description of the Hormonal and Epigenetic Regulators of Growth (HERO-G) study. This prospective cohort study from rural Gambia, West Africa, followed mothers and children longitudinally from pre-conception, through pregnancy, delivery, and to two years of child age A total of 251 eligible mother-infant pairs were recruited into the HERO-G study, with 206 (82%) followed up until two years of age. Women were seen at scheduled antenatal appointments at 20, 28 and 36 weeks of gestation, and at delivery, where possible. Between one week and 12 months of age, infants were visited every second day for collection of detailed anthropometry and morbidity data. Infants identified as about to enter a growth faltering episode at these visits entered a more detailed 20-day protocol, with the collection of dried blood spots, anthropometry and body composition. All infants were seen for scheduled clinic visits at 3, 6, 9, 12, 18 and 24 months of age for clinical examination and venous blood draw. Data from the HERO-G study is being used to explore three major mechanistic pathways influencing growth: 1) genome-wide investigations for signatures of epigenetic effects on any loci that might affect growth; 2) frequent anthropometric measurement coupled with non-invasive monitoring for rapid identification and interrogation of real-time faltering patterns and aetiology; 3) focused measurement of hormones and cytokines that act together in an integrated manner, both in utero and after birth, to coordinate patterns of growth with immune activation, inflammation, and nutritional status. F1000 Research Limited 2020-02-24 /pmc/articles/PMC7921526/ /pubmed/33693312 http://dx.doi.org/10.12688/gatesopenres.13101.1 Text en Copyright: © 2020 Moore SE et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Moore, Sophie E.
Doel, Andrew M.
Ong, Ken K.
Dunger, David B.
Affara, Nabeel A.
Prentice, Andrew M.
Bernstein, Robin M.
Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title_full Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title_fullStr Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title_full_unstemmed Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title_short Identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural African fetuses and infants: Project protocol and cohort description
title_sort identification of nutritionally modifiable hormonal and epigenetic drivers of positive and negative growth deviance in rural african fetuses and infants: project protocol and cohort description
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921526/
https://www.ncbi.nlm.nih.gov/pubmed/33693312
http://dx.doi.org/10.12688/gatesopenres.13101.1
work_keys_str_mv AT mooresophiee identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT doelandrewm identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT ongkenk identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT dungerdavidb identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT affaranabeela identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT prenticeandrewm identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT bernsteinrobinm identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription
AT identificationofnutritionallymodifiablehormonalandepigeneticdriversofpositiveandnegativegrowthdevianceinruralafricanfetusesandinfantsprojectprotocolandcohortdescription